ASSESSMENT OF THE EFFECTIVENESS OF THE USE OF FLUCONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN THE ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS

被引：0
|
作者：
Revilla Calvo, N. [1 ]
Garcia-Gutierrez, V [1 ]
Herrera, P. [1 ]
Calbacho, M. [1 ]
Chinea, A. [1 ]
Jimenez, A. [1 ]
Fonseca, J. [1 ]
Saavedra, I [1 ]
Lopez-Jimenez, J. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Serv Hematol & Hemoterapia, Madrid, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-150
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [1] Comparative Analysis Fluconazole Vs. Posaconazole As Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Patients
    Teo, Constance Jeanne
    Koh, Liang Piu
    Sia, Charmaine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S188 - S188
  • [2] ANTIBIOTIC PROPHYLAXIS SYSTEMATICS IN THE ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS INDICATED?
    Lopez Pereira, B.
    Bermudez, A.
    Lopez-Duarte, M.
    Yanez, L.
    Colorado, M.
    Richard, C.
    Conde, E.
    HAEMATOLOGICA, 2015, 100 : 291 - 291
  • [3] Fluconazole 200 mg Daily As Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Review
    Maher, Keri Renee
    McBride, Ali
    Chen, Christopher Chun Man
    Lim, Melissa
    Majeed, Aneela
    Hunt, Taylor
    Farooqui, Sarmad Riaz
    Riddle, Zach
    Yeager, Andrew M.
    Anwer, Faiz
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S181 - S181
  • [4] ANTIFUNGAL PROPHYLAXIS WITH FLUCONAZOLE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Gonzalez, A. J.
    Palomo, P.
    Gutierrez, L.
    Martinez, D.
    Arija, E.
    Martinez-Mugica, C.
    Gonzalez, A. P.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    HAEMATOLOGICA, 2014, 99 : 714 - 714
  • [5] Itraconazole vs. fluconazole for antifungal prophylaxis in allogeneic stem-cell transplant patients
    Winston, D. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 91 - 96
  • [6] Comparative analysis of fluconazole versus posaconazole as antifungal prophylaxis in allogeneic haematopoietic cell transplant patients
    Teo, C.
    Wong, Z.
    Poon, M. L. M.
    Tan, B.
    Tan, L. K.
    Lim, Z. Y.
    Lim, S.
    Koh, L. P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S323 - S323
  • [7] Cost-effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic stem cell transplant
    Walker, Brandon S.
    Schmidt, Robert L.
    Tantravahi, Srinivas
    Kim, Kibum
    Hanson, Kimberly E.
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (05)
  • [8] Antifungal Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
    Braccia, Deborah
    Stone, Patricia
    Gold, Heather Taffet
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : E47 - E47
  • [9] SECONDARY ANTIFUNGAL PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT: THE NIGUARDA HOSPITAL EXPERIENCE
    Ferrari, S.
    Zancanella, M.
    Zucchetti, E.
    Grillo, G.
    Cairoli, R.
    Nosari, A.
    HAEMATOLOGICA, 2016, 101 : 629 - 630
  • [10] Antifungal prophylaxis with fluconazole or fluconazole followed by posaconazole in high risk patients in allogeneic setting
    Miranda, Nuno
    Nunes, Catarina
    Gomez, Catalina
    Gomes, Vera
    Jorge, Sofia
    Teixeira, Gilda
    Ferreira, Isabelina
    Leal-da-Costa, Fernando
    Abecasis, Manuel
    BONE MARROW TRANSPLANTATION, 2019, 54 : 444 - 444
12345